Zobrazeno 1 - 10
of 13
pro vyhledávání: '"MacArthur IC"'
Autor:
Henssen, AG, Koche, R, Zhuang, J, Jiang, E, Reed, C, Eisenberg, A, Still, E, MacArthur, IC, Rodríguez-Fos, E, Gonzalez, S, Puiggròs, M, Blackford, AN, Mason, CE, De Stanchina, E, Gönen, M, Emde, A-K, Shah, M, Arora, K, Reeves, C, Socci, ND, Perlman, E, Antonescu, CR, Roberts, CWM, Steen, H, Mullen, E, Jackson, SP, Torrents, D, Weng, Z, Armstrong, SA, Kentsis, A
Genomic rearrangements are a hallmark of human cancers. Here, we identify the piggyBac transposable element derived 5 (PGBD5) gene as encoding an active DNA transposase expressed in the majority of childhood solid tumors, including lethal rhabdoid tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc1dbeb3d485d24124d71dc7ec5d0bab
Autor:
MacArthur IC; Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, 1301 Morris Park Ave, Bronx, NY 1046142, USA.; Department of Genetics, Albert Einstein College of Medicine, 1301 Morris Park Ave, Bronx, NY 10461, USA.; Department of Developmental & Molecular Biology, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA., Ma L; Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, 1301 Morris Park Ave, Bronx, NY 1046142, USA.; Department of Genetics, Albert Einstein College of Medicine, 1301 Morris Park Ave, Bronx, NY 10461, USA.; Department of Developmental & Molecular Biology, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA., Huang CY; Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, 1301 Morris Park Ave, Bronx, NY 1046142, USA.; Department of Genetics, Albert Einstein College of Medicine, 1301 Morris Park Ave, Bronx, NY 10461, USA.; Department of Developmental & Molecular Biology, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA., Bhavsar H; Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, 1301 Morris Park Ave, Bronx, NY 1046142, USA.; Department of Genetics, Albert Einstein College of Medicine, 1301 Morris Park Ave, Bronx, NY 10461, USA.; Department of Developmental & Molecular Biology, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA., Suzuki M; Department of Nutrition, Texas A&M University, 2253 TAMU, Carter Mattil 214A, College Station, TX 77840, USA., Dawlaty MM; Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, 1301 Morris Park Ave, Bronx, NY 1046142, USA.; Department of Genetics, Albert Einstein College of Medicine, 1301 Morris Park Ave, Bronx, NY 10461, USA.; Department of Developmental & Molecular Biology, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA.
Publikováno v:
Science advances [Sci Adv] 2024 Aug 30; Vol. 10 (35), pp. eado5424. Date of Electronic Publication: 2024 Aug 28.
Autor:
Dorado García H; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine, Berlin, Germany., Pusch F; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany., Bei Y; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine, Berlin, Germany., von Stebut J; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Ibáñez G; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Guillan K; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Imami K; Max Delbrück Center for Molecular Medicine, Berlin, Germany., Gürgen D; Experimental Pharmacology and Oncology (EPO), Berlin, Germany., Rolff J; Experimental Pharmacology and Oncology (EPO), Berlin, Germany., Helmsauer K; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Meyer-Liesener S; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Charité Campus Buch, Lindenberger Weg 80, 13125, Berlin, Germany., Timme N; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Bardinet V; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Chamorro González R; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine, Berlin, Germany., MacArthur IC; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Chen CY; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Schulz J; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Wengner AM; Bayer AG, Berlin, Germany., Furth C; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Lala B; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Eggert A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Seifert G; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Hundsoerfer P; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Kirchner M; Max Delbrück Center for Molecular Medicine, Berlin, Germany.; Berlin Institute of Health, 10178, Berlin, Germany., Mertins P; Max Delbrück Center for Molecular Medicine, Berlin, Germany.; Berlin Institute of Health, 10178, Berlin, Germany., Selbach M; Max Delbrück Center for Molecular Medicine, Berlin, Germany., Lissat A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Dubois F; Institute of pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Junior Clinician Scientist Program, Charitéplatz 1, 10117, Berlin, Germany., Horst D; Institute of pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Schulte JH; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Spuler S; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Charité Campus Buch, Lindenberger Weg 80, 13125, Berlin, Germany.; Berlin Institute of Health, 10178, Berlin, Germany.; Department of chemistry, biochemistry and pharmacy, Free University of Berlin, Berlin, Germany., You D; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Dela Cruz F; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Kung AL; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Haase K; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany., DiVirgilio M; Max Delbrück Center for Molecular Medicine, Berlin, Germany., Scheer M; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Ortiz MV; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Henssen AG; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany. henssenlab@gmail.com.; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany. henssenlab@gmail.com.; Max Delbrück Center for Molecular Medicine, Berlin, Germany. henssenlab@gmail.com.; Berlin Institute of Health, 10178, Berlin, Germany. henssenlab@gmail.com.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany. henssenlab@gmail.com.
Publikováno v:
Nature communications [Nat Commun] 2022 Jul 25; Vol. 13 (1), pp. 4297. Date of Electronic Publication: 2022 Jul 25.
Autor:
MacArthur IC; Department of Genetics, Albert Einstein College of Medicine, Bronx, NY, United States.; Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY, United States.; Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY, United States., Dawlaty MM; Department of Genetics, Albert Einstein College of Medicine, Bronx, NY, United States.; Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY, United States.; Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY, United States.
Publikováno v:
Frontiers in cell and developmental biology [Front Cell Dev Biol] 2021 Feb 18; Vol. 9, pp. 645335. Date of Electronic Publication: 2021 Feb 18 (Print Publication: 2021).
Autor:
MacArthur RB; Rockefeller University Hospital Pharmacy, The Rockefeller University, New York, NY, USA., Bentur OS; Allen and Frances Adler Laboratory of Blood and Vascular Biology, The Rockefeller University, New York, NY, USA., MacArthur IC; Medical Scientist Training Program, Albert Einstein College of Medicine, Bronx, NY, USA., Bartoo AS; Pharmacy Department, Mayo Clinic, Rochester, MN, USA., Capozzi DL; Ambulatory Oncology Pharmacy Services, Hospital of the University of Pennsylvania Pharmacy Department, Philadelphia, PA, USA., Christensen JA; Pharmacy Department, Mayo Clinic, Rochester, MN, USA., Johnson AL; Rockefeller University Hospital Pharmacy, The Rockefeller University, New York, NY, USA., Patel K; Pharmacy Department, Duke University Hospital, Durham, NC, USA., Coller BS; Allen and Frances Adler Laboratory of Blood and Vascular Biology, The Rockefeller University, New York, NY, USA.
Publikováno v:
Journal of clinical and translational science [J Clin Transl Sci] 2021 Feb 18; Vol. 5 (1), pp. e108. Date of Electronic Publication: 2021 Feb 18.
Autor:
Henssen AG; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Koche R; Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhuang J; Program in Bioinformatics and Integrative Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA., Jiang E; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Reed C; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Eisenberg A; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Still E; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., MacArthur IC; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rodríguez-Fos E; Joint BSC-CRG-IRB Research Program in Computational Biology, Barcelona Supercomputing Center (BSC-CNS), Barcelona, Spain., Gonzalez S; Joint BSC-CRG-IRB Research Program in Computational Biology, Barcelona Supercomputing Center (BSC-CNS), Barcelona, Spain., Puiggròs M; Joint BSC-CRG-IRB Research Program in Computational Biology, Barcelona Supercomputing Center (BSC-CNS), Barcelona, Spain., Blackford AN; The Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK., Mason CE; Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY, USA., de Stanchina E; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gönen M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Emde AK; New York Genome Center, New York, NY, USA., Shah M; New York Genome Center, New York, NY, USA., Arora K; New York Genome Center, New York, NY, USA., Reeves C; New York Genome Center, New York, NY, USA., Socci ND; Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Perlman E; Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA., Antonescu CR; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Roberts CWM; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA., Steen H; Department of Pathology, Boston Children's Hospital, Boston, MA, USA., Mullen E; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Jackson SP; The Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK.; Department of Biochemistry, University of Cambridge, Cambridge, UK.; The Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Torrents D; Joint BSC-CRG-IRB Research Program in Computational Biology, Barcelona Supercomputing Center (BSC-CNS), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Weng Z; Program in Bioinformatics and Integrative Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA., Armstrong SA; Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, Cornell University, New York, NY, USA.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kentsis A; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. kentsisresearchgroup@gmail.com.; Weill Cornell Medical College, Cornell University, New York, NY, USA. kentsisresearchgroup@gmail.com.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. kentsisresearchgroup@gmail.com.
Publikováno v:
Nature genetics [Nat Genet] 2020 Nov; Vol. 52 (11), pp. 1265.
Autor:
Koche RP; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA. kocher@mskcc.org., Rodriguez-Fos E; Barcelona Supercomputing Center, Joint Barcelona Supercomputing Center-Centre for Genomic Regulation-Institute for Research in Biomedicine Research Program in Computational Biology, Barcelona, Spain., Helmsauer K; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Burkert M; Department of Biology, Humboldt University, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; Max Delbrück Center for Molecular Medicine, Berlin, Germany., MacArthur IC; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Maag J; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chamorro R; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Munoz-Perez N; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Puiggròs M; Barcelona Supercomputing Center, Joint Barcelona Supercomputing Center-Centre for Genomic Regulation-Institute for Research in Biomedicine Research Program in Computational Biology, Barcelona, Spain., Garcia HD; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Bei Y; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Röefzaad C; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Bardinet V; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Szymansky A; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Winkler A; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Thole T; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Timme N; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Kasack K; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Fuchs S; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Klironomos F; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Thiessen N; Berlin Institute of Health, Berlin, Germany., Blanc E; Berlin Institute of Health, Berlin, Germany., Schmelz K; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Künkele A; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Hundsdörfer P; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Rosswog C; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Theissen J; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Beule D; Berlin Institute of Health, Berlin, Germany., Deubzer H; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Berlin, Germany., Sauer S; Berlin Institute of Health, Berlin, Germany., Toedling J; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Fischer M; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany., Hertwig F; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Schwarz RF; Max Delbrück Center for Molecular Medicine, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Eggert A; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Torrents D; Barcelona Supercomputing Center, Joint Barcelona Supercomputing Center-Centre for Genomic Regulation-Institute for Research in Biomedicine Research Program in Computational Biology, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Schulte JH; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Henssen AG; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany. henssenlab@gmail.com.; Berlin Institute of Health, Berlin, Germany. henssenlab@gmail.com.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany. henssenlab@gmail.com.; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Berlin, Germany. henssenlab@gmail.com.
Publikováno v:
Nature genetics [Nat Genet] 2020 Apr; Vol. 52 (4), pp. 464.
Autor:
Timme N; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Experimental and Clinical Research Center (ECRC) of the Charité and the Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany., Han Y; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Experimental and Clinical Research Center (ECRC) of the Charité and the Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany., Liu S; Department of Chemistry, UMass Boston, Boston, MA, USA., Yosief HO; Department of Chemistry, UMass Boston, Boston, MA, USA., García HD; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Experimental and Clinical Research Center (ECRC) of the Charité and the Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany., Bei Y; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Experimental and Clinical Research Center (ECRC) of the Charité and the Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany., Klironomos F; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., MacArthur IC; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Experimental and Clinical Research Center (ECRC) of the Charité and the Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany., Szymansky A; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Institute of Biology, Freie Universität Berlin, Germany., von Stebut J; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Experimental and Clinical Research Center (ECRC) of the Charité and the Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany., Bardinet V; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Experimental and Clinical Research Center (ECRC) of the Charité and the Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany., Dohna C; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Künkele A; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Deutsches Konsortium für Translationale Krebsforschung, Berlin, Germany., Rolff J; Experimental Pharmacology and Oncology Berlin-Buch GmbH (EPO), Berlin, Germany., Hundsdörfer P; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Berlin Institute of Health, Berlin, Germany; Helios Klinikum Berlin-Buch, Germany., Lissat A; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Seifert G; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Eggert A; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Schulte JH; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Deutsches Konsortium für Translationale Krebsforschung, Berlin, Germany; Berlin Institute of Health, Berlin, Germany., Zhang W; Department of Chemistry, UMass Boston, Boston, MA, USA., Henssen AG; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Experimental and Clinical Research Center (ECRC) of the Charité and the Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany; Deutsches Konsortium für Translationale Krebsforschung, Berlin, Germany; Berlin Institute of Health, Berlin, Germany. Electronic address: anton.henssen@charite.de.
Publikováno v:
Translational oncology [Transl Oncol] 2020 Feb; Vol. 13 (2), pp. 221-232. Date of Electronic Publication: 2019 Dec 21.
Autor:
Koche RP; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA. kocher@mskcc.org., Rodriguez-Fos E; Barcelona Supercomputing Center, Joint Barcelona Supercomputing Center-Centre for Genomic Regulation-Institute for Research in Biomedicine Research Program in Computational Biology, Barcelona, Spain., Helmsauer K; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Burkert M; Department of Biology, Humboldt University, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; Max Delbrück Center for Molecular Medicine, Berlin, Germany., MacArthur IC; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Maag J; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chamorro R; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Munoz-Perez N; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Puiggròs M; Barcelona Supercomputing Center, Joint Barcelona Supercomputing Center-Centre for Genomic Regulation-Institute for Research in Biomedicine Research Program in Computational Biology, Barcelona, Spain., Dorado Garcia H; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Bei Y; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Röefzaad C; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Bardinet V; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Szymansky A; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Winkler A; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Thole T; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Timme N; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Kasack K; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Fuchs S; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Klironomos F; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Thiessen N; Berlin Institute of Health, Berlin, Germany., Blanc E; Berlin Institute of Health, Berlin, Germany., Schmelz K; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Künkele A; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Hundsdörfer P; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Rosswog C; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Theissen J; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Beule D; Berlin Institute of Health, Berlin, Germany., Deubzer H; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Berlin, Germany., Sauer S; Berlin Institute of Health, Berlin, Germany., Toedling J; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Fischer M; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany., Hertwig F; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Schwarz RF; Max Delbrück Center for Molecular Medicine, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Eggert A; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Torrents D; Barcelona Supercomputing Center, Joint Barcelona Supercomputing Center-Centre for Genomic Regulation-Institute for Research in Biomedicine Research Program in Computational Biology, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Schulte JH; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Henssen AG; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany. henssenlab@gmail.com.; Berlin Institute of Health, Berlin, Germany. henssenlab@gmail.com.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany. henssenlab@gmail.com.; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Berlin, Germany. henssenlab@gmail.com.
Publikováno v:
Nature genetics [Nat Genet] 2020 Jan; Vol. 52 (1), pp. 29-34. Date of Electronic Publication: 2019 Dec 16.
Autor:
MacArthur IC; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Medical Scientist Training Program, Albert Einstein College of Medicine, New York, New York, USA., Bei Y; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Garcia HD; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Ortiz MV; Department of Pediatrics and Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Toedling J; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Klironomos F; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Rolff J; Experimental Pharmacology and Oncology, Berlin, Germany., Eggert A; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium, Heidelberg, Germany.; Berlin Institute of Health, Berlin, Germany., Schulte JH; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium, Heidelberg, Germany.; Berlin Institute of Health, Berlin, Germany., Kentsis A; Department of Pediatrics and Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Departments of Pharmacology, Pediatrics, and Physiology and Biophysics, Weill Medical College of Cornell University, New York, New York, USA., Henssen AG; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium, Heidelberg, Germany.; Berlin Institute of Health, Berlin, Germany.; Experimental and Clinical Research Center of the Max Delbrück Center and Charité Berlin, Berlin, Germany.
Publikováno v:
JCI insight [JCI Insight] 2019 Apr 18; Vol. 5. Date of Electronic Publication: 2019 Apr 18.